| Financial Year |
March 31 2023 |
| Monetary Funds |
1,126,517,154.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,831,725.22 |
| Accounts Receivable |
2,049,656,781.25 |
| Advances to Suppliers |
52,982,019.65 |
| Other Receivables |
169,949,726.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
370,670.74 |
| Inventories |
642,679,778.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,910,501.65 |
| Total Current Assets |
5,342,063,029.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,727,110.09 |
| Investment Properties |
302,845,064.92 |
| Fixed Assetes |
779,751,046.52 |
| Under-construction Projects |
1,515,647.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,206,305.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,638,952.37 |
| Deferred Income Tax Assets |
132,760,547.85 |
| Other Non-Current Assets |
10,702,725.25 |
| Sub-Total of Non-Current Assets |
1,475,185,186.10 |
| Total Assets |
6,817,248,215.19 |
| Short-Term Loans |
1,874,999.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,610,710.76 |
| Accounts Payable |
1,166,128,069.48 |
| Accounts Received In Advance |
5,329,361.10 |
| Employee Compensation Payable |
297,428,122.57 |
| Taxes Payable |
41,817,144.71 |
| Interest Payable |
9,320,532.16 |
| Dividend Payable |
1,842,103.84 |
| Other payables |
234,317,102.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
501,791,690.66 |
| Other Current Liabilities |
992,157.84 |
| Sub-Total of Current Liabilities |
2,724,752,661.73 |
| Long-term Loans |
725,020,000.00 |
| Bonds Payable |
320,745,099.86 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,413.52 |
| Deferred Income Tax Liabilities |
49,561,039.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,095,331,552.96 |
| Total Liabilities |
3,820,084,214.69 |
| Paid-In Capital(Or Share Stock) |
324,341,585.00 |
| Capital Surplus |
957,847,876.19 |
| Surplus Reserve |
161,290,506.37 |
| LESS:Treasury Stock |
12,693,407.50 |
| Undistributed Profits |
1,425,973,708.40 |
| Minority Stockholder's Interest |
76,792,253.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,920,371,746.92 |
| Owner's Equity（Stockholder's Equity） |
2,997,164,000.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,817,248,215.19 |
